Official announcements
Search narrowed by
messages in brief
|
13/02/2020
According to § 14 of the Federal Disability Equality Act (BGStG) Marketing authorization holders are obliged to provide their Package Leaflets in an accessible format
messages in brief
|
10/02/2020
Currently, in the area of open communications, an incorrect display of the letter symbol may occur during ongoing procedures.
messages in brief
|
24/01/2020
The National Immunization Schedule 2020 is now available.
messages in brief
|
21/10/2019
The second round table discussing the availability of medicines in Austria took place on October 15, 2019.
Safety warnings
|
messages in brief
|
17/09/2019
Measures at EU level At the request of the European Commission, the European Medicines Agency (EMA) has begun reviewing medicines containing ranitidine after investigations found contamination with N-nitrosodimethylamine (NDMA). NDMA is classified as…
messages in brief
|
26/07/2019
Situation in Austria Imurek-50 mg Film-Coated Tablets are currently temporarily unavailable due to increased demand beyond national borders, and associated capacity constraints at the manufacturer. This information is publicly available on the…
messages in brief
|
18/07/2019
Please find new and updated FAQ's regarding "Accessible Patient Information Leaflet" at https://www.basg.gv.at/en/medicines/faqs-about-medicinal-products/accessible-patient-information-leaflet/ .
messages in brief
|
18/07/2019
The concept of parallel submission in official control authority batch release means that the applicant sends samples to the BASG-OMCL (Official Medicines Control Laboratory) while he is still testing them himself. Complete documentation is not…
messages in brief
|
17/07/2019
Manufacturers of an implantable device shall provide information for identification of the device on an implant card in accordance with Article 18 MDR. More detailed guidance on a uniform format of an implant card have now been published on the…
messages in brief
|
16/07/2019
For more information on this topic, follow the link to the security features .